SCHEMBL30281179

SCHEMBL30281179

Cn1nc(C(N)=O)c(C2CC(F)(F)C2)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30281156 0.86 — —
SCHEMBL29252887 0.85 KDM1A (0.34) —
SCHEMBL28976609 0.71 TEAD1 (0.36) —
SCHEMBL28917325 0.64 KDM4E (0.50) —
SCHEMBL26053111 0.64 — —
SCHEMBL25211561 0.62 — —
SCHEMBL30526884 0.61 PARP1 (0.44) —
SCHEMBL30281268 0.61 SMN1; SMN2 (0.36) —
SCHEMBL25371391 0.61 TDP1 (0.30) —
SCHEMBL29241719 0.61 KDM4E (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4143195-A1 IMIDAZOPYRIDAZINES AS MODULATORS OF IL-17 Janssen Pharmaceutica NV (BE) 2023-03-08 — — EP disclosed
Send feedback